NEW YORK (Reuters Health) – New research indicates that tenofovir 300 mg-emtricitabine 200 mg (TDF-FTC) is comparable to abacavir 600 mg-lamivudine 300 mg (ABC-3TC) in anti-HIV efficacy but…
NEW YORK (Reuters Health) – Antiretroviral therapy does not adversely affect lung function in HIV-infected patients and may actually have a beneficial effect, according to study findings presented…
NEW YORK (Reuters Health) – Newly updated guidelines for managing persons infected with HIV recommend that all patients undergo genotypic resistance testing even if there are no immediate…
NEW YORK (Reuters Health) – Even though they are at increased risk of invasive cervical cancer, nearly one in four HIV-positive women in the US who were recently…
NEW YORK (Reuters Health) – In a prospective, randomized trial, a single daily tablet containing efavirenz, emtricitabine, and tenofovir (Atripla; Bristol Myers Squibb & Gilead Sciences LLC) maintained…
John Flaherty, MD, Professor of Medicine, Northwestern University, discusses HIV infection, latest trends in treatment and what a hospitalist needs to know. Summary: 1.There is a trend toward…
NEW YORK (Reuters Health) – Sperm washing and in-vitro fertilization (IVF) with intracytoplasmic sperm infection (ICSI) can safely achieve pregnancy in couples in which the male is HIV-positive,…
Jeffrey M. Weinberg, MD, Associate Chair of the Department of Dermatology at St. Luke’s-Roosevelt Hospital Center reviews the pathogenesis and treatment of human immunodeficiency virus (HIV)–associated psoriasis. Psoriasis…
NEW YORK (Reuters Health) – Initiation of highly active antiretroviral therapy (HAART) during the first year of life among infants vertically infected with HIV preserves the normal immune…
NEW YORK (Reuters Health) – The two commercially available Mycobacterium tuberculosis-specific interferon-gamma release assays show excellent agreement with each other. As far more accurate indicators of latent TB…